NovaBridge Biosciences (NBP) Research & Development (2019 - 2025)
NovaBridge Biosciences' Research & Development was -$55.66 million in Q4 2025, compared with -$6.03 million a year earlier.
Powered by 
Analysis
NovaBridge Biosciences (NBP) Research & Development (2019 - 2025) Analysis & Trends
For FY2025, Research & Development at NovaBridge Biosciences came in at -$62.91 million.
- In earlier years, Research & Development was -$21.77 million in FY2024, -$21.45 million in FY2023, -$22.55 million in FY2022 and -$190.34 million in FY2021.
- The Q4 2025 figure marks the lowest quarterly Research & Development since Q4 2022.
- Per Business Quant data, NBP's Research & Development in the three quarters before Q4 2025 was -$3.18 million (Q3 2025), -$3.29 million (Q2 2025) and -$777,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | NovaBridge Biosciences | 149.78 Mn | 149.78 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -55.66 Mn |
| Sep 30, 2025 | -3.18 Mn |
| Jun 30, 2025 | -3.29 Mn |
| Mar 31, 2025 | -777,000.00 |
| Dec 31, 2024 | -6.03 Mn |
| Sep 30, 2024 | -4.48 Mn |
| Jun 30, 2024 | -5.20 Mn |
| Mar 31, 2024 | -6.06 Mn |
| Dec 31, 2023 | -8.16 Mn |
| Sep 30, 2023 | -5.09 Mn |
| Jun 30, 2023 | -4.29 Mn |
| Dec 31, 2020 | -43.19 Mn |
| Sep 30, 2020 | -37.01 Mn |
| Dec 31, 2019 | -37.18 Mn |
| Sep 30, 2019 | -44.70 Mn |
API Access
NovaBridge Biosciences Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();